AddLife Investor Relations Material

AddLife AB, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. AddLife's products are used in the development of cell therapies: cellular immunotherapy for autoimmune disease at institutions such as Scripps Research Institute Florida; clinical translation for Dystrophin gene therapy by partners such as Nationwide Children's Hospital; and phenotyping services for clinical researchers at Rush University Medical Center. It also offers products for biopharmaceutical development, including cell sorters from Abacus Biosystems; high-content screening plates for use in the drug discovery process; and automated microscope slide stainer products for automated image analysis and high content analysis. The company is based in Stockholm, Sweden.